Jiuyuan Gene AGM Clears All Items, Declares RMB0.57-per-10-Share Final Dividend and Scraps Supervisory Committee

Bulletin Express
06/15

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene, 02566) announced that all 17 resolutions tabled at the 15 June 2026 annual general meeting were approved by poll, with support ratios ranging from 99.69% to 100.00%.

Shareholder turnout reached 117.72 million voting shares, representing 48.74% of the 241.52 million issued shares carrying voting rights, after excluding 3.88 million treasury shares.

Key resolutions and implications 1. Profit Distribution: A final dividend of RMB0.57 (tax-inclusive) for every 10 shares was approved. The payout will be converted into HKD for H-share investors at the exchange rate of RMB1 = HK$1.1498, translating to HK$0.6554 per 10 H shares. The H-share register will close from 22 June 2026 to 24 June 2026, and the ex-dividend record date is 18 June 2026.

2. Corporate Governance Changes: • The Supervisory Committee has been abolished, with its oversight duties transferred to the Board’s audit committee. • Amendments to the Articles of Association, Board Rules and Shareholders’ Meeting Rules were endorsed.

3. Board Composition: • Dr. Huang Wenli was appointed an independent non-executive director, effective immediately through the end of the first Board term. • Mr. Xu Feihu, formerly a supervisor, was elected employee-representative director at the company’s employee meeting on the same day.

4. Authorisations: • Issue and Repurchase Mandates were renewed, granting the Board flexibility for future capital-market activities. • Ernst & Young and Ernst & Young Hua Ming LLP were re-appointed as auditors for 2026.

Tax Treatment Dividend withholding tax will be deducted at 10% for non-resident enterprise shareholders. Individual foreign shareholders remain temporarily exempt from PRC individual income tax under prevailing regulations.

Scrutineers Computershare Hong Kong Investor Services Limited, along with two shareholder representatives and one company supervisor, verified the poll count.

The Board welcomed the new appointments and expressed appreciation to outgoing supervisors for their service.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10